The STROKE-IFN trial highlighted that pneumonia independently increased the odds of an unfavorable outcome at 3 months post-stroke [odds ratio (OR), 9.64 (5.06–18.42)] (163). The gene discussed is IFNA1; the disease is stroke disorder.